Eva Carrasco

Characterization of uncertainty in the classification of multivariate assays: application to PAM50 centroid-based genomic predictors for breast cancer treatment plans

Miguel Martín, Julio C. Facelli, Mark T. W. Ebbert, 2011, Journal of Clinical Bioinformatics.

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Eva Carrasco, Emilio Alba, Ana Lluch, 2018, Oncotarget.

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

Donald A. Berry, Mark T. W. Ebbert, Charles M. Perou, 2013, Breast Cancer Research and Treatment.

PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers

Mark T. W. Ebbert, Charles M Perou, Roy R. L. Bastien, 2012, BMC Medical Genomics.